These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9155051)

  • 21. Studies of the deleted in colorectal cancer gene in normal and neoplastic tissues.
    Fearon ER; Ekstrand BC; Hu G; Pierceall WE; Reale MA; Bigner SH
    Cold Spring Harb Symp Quant Biol; 1994; 59():637-43. PubMed ID: 7587124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma].
    Li PL; Liu MM; Ni J
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.
    Schmitt CA; Thaler KR; Wittig BM; Kaulen H; Meyer zum Büschenfelde KH; Dippold WG
    Br J Cancer; 1998 Feb; 77(4):588-94. PubMed ID: 9484816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma.
    Johnson-Pais TL; Nellissery MJ; Ammerman DG; Pathmanathan D; Bhatia P; Buller CL; Leach RJ; Hansen MF
    Int J Cancer; 2003 Jun; 105(2):285-8. PubMed ID: 12673693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of the tumour suppressor gene DCC in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Takita J; Yokota J; Hanada R; Yamamoto K; Bessho F; Yanagisawa M; Hayashi Y
    Eur J Cancer; 1997 Oct; 33(12):1962-5. PubMed ID: 9516833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of the expression of tumor suppressor gene DCC in human gliomas.
    Nakatani K; Yoshimi N; Mori H; Sakai H; Shinoda J; Andoh T; Sakai N
    J Neurooncol; 1998 Dec; 40(3):237-42. PubMed ID: 10066096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma.
    Höhne MW; Halatsch ME; Kahl GF; Weinel RJ
    Cancer Res; 1992 May; 52(9):2616-9. PubMed ID: 1314700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation and expression of the DCC gene in human lung cancer.
    Kohno T; Sato T; Takakura S; Takei K; Inoue K; Nishioka M; Yokota J
    Neoplasia; 2000; 2(4):300-5. PubMed ID: 11005564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.
    Pasic I; Shlien A; Durbin AD; Stavropoulos DJ; Baskin B; Ray PN; Novokmet A; Malkin D
    Cancer Res; 2010 Jan; 70(1):160-71. PubMed ID: 20048075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
    Bamias AT; Bai MC; Agnantis NJ; Michael MC; Alamanos YP; Stefanaki SV; Razi ED; Skarlos DV; Kappas AM; Pavlidis NA
    Cancer Invest; 2003 Jun; 21(3):333-40. PubMed ID: 12901278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DCC gene alteration in human endometrial carcinomas.
    Gima T; Kato H; Honda T; Imamura T; Sasazuki T; Wake N
    Int J Cancer; 1994 May; 57(4):480-5. PubMed ID: 7514150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of DCC mRNA in gastric and colorectal cancer.
    Kataoka M; Okabayashi T; Orita K
    Surg Today; 1995; 25(12):1001-7. PubMed ID: 8645930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
    Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
    Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor gene allelic loss in human renal cancers.
    Brooks JD; Bova GS; Marshall FF; Isaacs WB
    J Urol; 1993 Oct; 150(4):1278-83. PubMed ID: 8371415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant.
    Yoshida Y; Itoh F; Endo T; Hinoda Y; Imai K
    Int J Cancer; 1998 Dec; 79(6):634-9. PubMed ID: 9842974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma.
    Saegusa M; Hashimura M; Hara A; Okayasu I
    Cancer; 1999 Jan; 85(2):453-64. PubMed ID: 10023715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DCC gene and leukemia].
    Miyake K; Inokuchi K
    Nihon Rinsho; 1992 Jun; 50(6):1358-62. PubMed ID: 1518158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.